Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups
and Laboratory Diagnostics
If there is any common theme to the different chapters of this White Paper on the laboratory industry, it is probably this: in the next couple of years, clinical laboratories will continue to have one foot in the past and one foot in the future. Simply put, lab administrators will continue to manage a laboratory originally …
Summary and Overview of Lab Industry Read More »
AS THE NEW YEAR’S EVE CELEBRATION RINGS OUT THE YEAR 2000 and welcomes 2001, THE DARK REPORT will celebrate more than five years of service to the clinical laboratory industry and the pathology profession. It has certainly been an extraordinary five years for laboratories throughout the United States and the world. All segments of the …
Converting Business Intelligence Into Lab Profits Read More »
INTRODUCTION: To celebrate five eventful years of service to the laboratory industry and pathology profession, THE DARK REPORT is pleased to present its first “White Paper” on the laboratory industry. Our goal is help laboratories and their suppliers accurately identify relevant market dynamics and understand how and why these market forces will affect the stability …
DARK REPORT Presents “White Paper” Summary Of Laboratory Industry Read More »
This chapter addresses the characteristics of the laboratory industry which define the starting point for changes and ongoing evolution. The eight business premises listed in this White Paper describe unique situations which directly influence the ability of clinical laboratories to serve the medical community. The relevance of these business premises becomes apparent whenever a laboratory …
Business Premises Underlying Lab Industry Dynamics Read More »
If analysis is to be accurate and objective, it must recognize and praise successful accomplishments while at the same time recognizing and criticizing failures. Human nature being what it is, however, criticism of failed business decisions is painful and bound to generate denials by the parties involved. One key element of a White Paper review …
Strategic Business Failures Of The Laboratory Industry During the 1990s Read More »
This section of the White Paper deals with the marketplace for laboratory services. For brevity and clarity, I will address five components: 1) independent commercial laboratories; 2) hospital-based laboratories; 3) esoteric, reference, and specialty testing laboratories; 4) anatomic pathology lab- oratories; and 5) diagnostics manufacturers and suppliers. These groups represent the basic divisions within the …
Competitive Dynamics In the Laboratory Testing Marketplace Read More »
EVERYONE IN THE CLINICAL LAB BUSINESS KNOWS that our business will soon be dominated by genetic and molecular testing technology. However, most lab administrators and pathologists believe that we are several years away from the widespread clinical use of such technology in laboratory testing. In principle, I would agree with that part of the popular wisdom. …
Genetics Tidal Wave is Rapidly Approaching Read More »
CEO SUMMARY: In many ways, 2000 was a relatively quiet year for laboratory organizations. This list of the ten biggest stories in the lab industry for 2000 demonstrates that the most innovative laboratory organizations in the United States are “raising the bar” for service and quality in the competitive marketplace. This will change the status …
Year’s Ten Biggest Stories Reveal Modest Changes Read More »
CEO SUMMARY: Despite a decade of consolidation, competition among the world’s largest diagnostics manufacturers remains intense. In response to this competition, Ortho-Clinical Diagnostics (OCD) is preparing a variety of new products and services for its clinical laboratory customers. It’s already exploring diagnostic opportunities in the emerging field of pharmacogenomics. In the field of laboratory management, …
Ortho-Clinical Diagnostics Embraces New Testing Technology Read More »
IT WAS A DISAPPOINTING TRIP to the public equity markets for Dynacare, Inc. last month. The lab company raised only $50 million in its initial public offering (IPO). Dynacare had hoped to harvest as much as $89 million from this IPO. Plans were to sell seven million shares at about $13 per share. But after …
Dynacare’s IPO is Funded, Specialty Labs’ IPO is Next Read More »
Copyright 2020 © The Dark Report. All rights reserved.
The Dark Report • 21806 Briarcliff Dr • Spicewood, TX 78669
Phone: 512-264-7103 • Toll Free Number: 800-560-6363
Email: customerservice@darkintelligencegroup.com